「9岁起始」策略提升HPV疫苗接种率:一项试点项目
在美国两家儿科诊所实施多层次项目(政策制定、医护人员教育、电子健康记录调整及疫苗宣传品)以促进9岁常规推荐HPV疫苗。项目实施后,9-10岁儿童HPV疫苗接种率中位数在城市诊所从8%升至41%、郊区诊所从3%升至23%;9-12岁儿童完成率分别从9%升至14%(p<0.001)和从6%升至16%(p<0.001)。
要点
- 9岁常规推荐HPV疫苗可提高9-10岁接种率中位数。
- 9-12岁HPV疫苗完成率在城市和郊区诊所均显著提高(p<0.001)。
- 医生疫苗推荐记录与HPV疫苗接种强相关。
核心结论
- 实施9岁常规推荐HPV疫苗的多层次项目可行且有效,可提高13岁前HPV疫苗完成率。
研究设计与样本
- 在2家儿科诊所实施多层次项目,包括政策制定、医护人员教育、电子健康记录调整和疫苗宣传品使用。
- 开展实施前6个月至实施后18个月的月度病历审查,并从电子健康记录获取9-12岁儿童季度数据。
主要发现
- 9-10岁儿童HPV疫苗接种率中位数在城市诊所从8%升至41%,在郊区诊所从3%升至23%。
- 9-12岁儿童HPV疫苗完成率在城市诊所从9%升至14%(p<0.001),在郊区诊所从6%升至16%(p<0.001)。
- 医生疫苗推荐记录与HPV疫苗接种强相关。
临床怎么用
- 在儿科诊所可通过政策、教育、电子健康记录和宣传品的多层次组合,推动9岁常规推荐HPV疫苗。
- 关注医生推荐记录,作为提升HPV疫苗接种的抓手。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Human papillomavirus (HPV) vaccine completion rates by 13 years remain suboptimal. Earlier HPV vaccination may result in improved timely completion rates. We aim to describe the impact of recommending HPV vaccine at 9 years of age on vaccine completion rates. METHODS: We implemented a multi-level program (including policy development, provider and office personnel education, electronic health record changes, and use of vaccine promotional items) to facilitate routine HPV vaccine recommendation at 9 years at 2 pediatric practices. Monthly chart reviews were performed 6 months before through 18 months after program implementation. Outcome measures included rates of HPV vaccination and documentation of HPV vaccine during the visit. Quarterly data (age, HPV vaccination status, gender, race, ethnicity, insurance, and primary care provider type) were obtained from the electronic health records of 9-12-year-olds served by the practice from baseline through 18 months after program implementation. RESULTS: Following program implementation, the median percentage of HPV vaccine uptake among 9-10-year-olds increased from 8% to 41% at the urban practice and from 3% to 23% at the suburban practice. Similarly, HPV vaccine completion rates among 9-12 year olds increased from 9% to 14%, p < 0.001 and from 6% to 16%, p < 0.001, respectively. Documentation of provider vaccine recommendation strongly correlated with HPV vaccination. CONCLUSION: Implementation of a multi-level program to routinely recommend the HPV vaccine at 9 years of age is feasible and effective in increasing in HPV vaccine completion by 13 years of age.
引用
- Malik S, Gu S, Sisskind J, et al. Increasing HPV vaccine uptake using a "start at 9"strategy: A pilot program. Vaccine. 2026. PMID: 41785678. doi:10.1016/j.vaccine.2026.128401
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。